
 ip joint pain in children with cerebral palsy and developmental dysplasia of the hip: why are the differences so huge? by unknown
Grzegorzewski et al. BMC Musculoskeletal Disorders 2014, 15:96
http://www.biomedcentral.com/1471-2474/15/96RESEARCH ARTICLE Open AccessHip joint pain in children with cerebral palsy and
developmental dysplasia of the hip: why are the
differences so huge?
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Backgrounds: Non-traumatic hip dislocation in children is most often observed in the course of developmental
dysplasia of the hip (DDH) and infantile cerebral palsy. The risk of pain sensations from dislocated hip joint
differentiates the discussed groups of patients. Will every painless hip joint in children with cerebral palsy painful in
the future?
Methods: Material included 34 samples of joint capsule and 34 femoral head ligaments, collected during open hip
joint reduction from 19 children with CP, GMFCS level V and from 15 children with DDH and unilateral hip
dislocation. All the children were surgically treated.
The density of nociceptive fibres was compared between the children with CP and DDH, using S-100 and substance
P monoclonal antibodies.
Results: More frequent positive immunohistochemical reaction to S-100 protein concerned structures of the femoral
head ligaments in children with CP and cartilage losses on the femoral head, when compared to the same structures
in children with DDH (p = 0.010). More frequent were found positive immunohistochemical reactions for S-100 protein
in the joint capsules of children with cartilage losses (p = 0.031) and pain ailments vs. the children with DDH (p = 0.027).
More frequent positive reaction to substance P concerned in femoral head ligaments in CP children and cartilage
lesions (p = 0.002) or with pain ailments (p = 0.001) vs. the DDH children.
Conclusions: Surgical treatment of hip joint dislocation should be regarded as a prophylactics of pain
sensations, induced by tissue sensitisation, inflammatory process development or articular cartilage defects.
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Non-traumatic hip dislocation in children is most often
observed in the course of developmental dysplasia of the
hip (DDH) and infantile cerebral palsy (CP) [1-3]. Beside
aetiology, these two groups of patients differ between
each other with the age, at which hip joint dislocation
occurs, the presence of deformities in other elements of
musculoskeletal system in children with CP and with an
increased risk of congenital malformations (torticollis or
clubfoot) in case of children with DDH [4,5]. In children
with DDH, pain is never suffered at the infantile age or* Correspondence: adian@gazeta.pl
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distribution, and reproduction in any mediumat initial walking phase, up till the end of the first decade
of life. When treatment is not applied, pain is sensed at
the earliest by teenage children [6,7]. In children with
dislocated hip joint in the course of cerebral palsy, pain
sensations were observed in 40%-84% of cases and kids
started to complain of pain 3-5 years later after putting
diagnosis hip dislocation [8-11]. Literature data indicate
that pain more often occurs in children with injured car-
tilage of the femoral head [12,13].
Hip pain results from the stimulation of free endings
of slow-conducting nerve fibres with nociceptive input.
This effect can be amplified by biochemical agents, such
as bradykinin or histamine, which may activate the end-
ings of nerve fibres, triggering pain, while other agents,
such as substance P or prostaglandins, mainly enhanceCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
Table 1 Pain and cartilage damage distribution in CP
patients
Patient no. Age Pain yes/no Cartilage damage in %
1. 11 Yes 30
2. 18 No 0
3. 12 No 0
4. 8 Yes 80
5. 7 Yes 80
6. 11 No 0
7. 8 Yes 0
8. 7 No 0
9. 13 Yes 80
10. 7 Yes 0
11. 12 Yes 60
12. 9 Yes 80
13. 13 No 0
14. 6 No 0
15. 7 Yes 80
16. 5 Yes 80
17. 8 Yes 40
18. 7 No 0
19. 11 No 0
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persistent noxious, mechanical, or thermal stimulation
input can be involved in developing or increasing central
sensitization and release processes, leading to or sup-
porting chronic pain.
Interestingly enough, pain sensations in children with
CP do not result only from degenerative changes in the
cartilage in consequence of irritating the exposed, inner-
vated subchondral layer of the femoral head, as pain
complaints are also observed in children without signifi-
cant cartilage lesions [13]. All to-date’s attempts to con-
firm that children with CP are predisposed to pain
sensation from dislocated hip joint have failed to provide
unequivocal results [13,14], and there is only a question
if an increased expression of substance P and S-100 pro-
tein in soft tissues of the joint could be regarded as the
cause of pain. An answer to this question could help de-
cide whether preventive, surgical open repositioning of
painless hip joints in children with cerebral palsy is a
justified procedure and if every painless joint will not
generate pain in future.
This question could be solved by a comparison of
nociceptors distribution densities and/or factors, pre-
disposing to inflammation development or sustaining
in soft tissues of the hip joint in children with its pain-
less dislocation in the course of DDH and in children
with painful and painless hip joint dislocation in the
course of CP.
Methods
The studied material included 34 samples of joint cap-
sule and 34 femoral head ligaments, collected during
open hip joint reduction from 19 consecutive non-
ambulatory children with CP, GMFCS level V (their age
range: 5–18 years; the mean age: 9 years 6 months; 10
males; 9 females) with unilateral hip joint dislocation
(the migration index >80%) (group 1) and from 15 chil-
dren with DDH and unilateral hip dislocation (the age
range: 2- 4 years; the mean age: 2.6 years; 11 females; 4
males) (group 2).
Children with CP were diagnosed with hip dislocation
a few weeks before the surgery. The exact time of dis-
location is unknown. All the children were surgically
treated because of presence of dislocated hip joint pain
or with the goal to prevent pain appearance. The func-
tional purpose of hip surgery was to improve the trunk
balance during sitting. During surgery, cartilage destruc-
tion levels were assessed by mapping of the cartilage le-
sions and comparing with the total femoral head surface.
Degenerative changes were assessed according to their
size as: large (>50% of femoral head surface); medium
(25%-50%) or small (<25%).
Primary caregivers were asked in compliance with
clinical anamnesis protocol about pain experienced bythe children in their care. Caregivers were questioned
about the incidence of chronic or incidental musculo-
skeletal pain localized around the hip joint during the
course of performing daily activities and rehabilitation
therapy. Pain was assessed on observed idiosyncratic or
expressive behavior, such as crying, moaning, agitation,
flinching or moving the body parts away. Pain intensity
was quantified, using the 11-point Numeric Rating Scale
(NRS-11), ranging from 0 = no pain to 10 = severe pain.
A subdivision into painless hip joints (NRS-11 from 0 to
2) – Group 1a, and painful hips (NRS-11 from 3 to 10)
was made still before clinical analysis to eliminate false-
positive indications – group 1b. The NRS-11 borderline
value of 2 (slight, occasional pain) was based on the au-
thors’ personal experiences. All the 9 children with car-
tilage damage felt hip pain. Two of the ten children
without cartilage damage felt pain as well (patient No. 7
and No. 10), while in other children without cartilage
damage the hip was painless (Table 1).
Children with DDH were not diagnosed with the hip
dislocation ultrasound screening program because their
parents failed to attend but, at the age from 6 to 8 months,
they were non surgically treated till the first year of life or
diagnosed later during routine paediatric examination and
referred to orthopaedic outpatient clinic. All the children
presented with hip joint luxation. Children were inde-
pendent ambulators with no identified systemic disorders
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caregivers reported any problems with pain, which would
have corresponded to NRS-11.
The samples, collected during surgery, were processed
for routine light microscopic observations. The tissue
samples were fixed for 24 hours in 4% buffered formal-
dehyde and embedded into paraffin. Then, 4 μm sections
were stained with haematoxylin and eosin (H&E) and
examined on an Olympus BX 50 light microscope. In
the H&E-stained specimens, the number of blood vessels
was evaluated in 10 visual fields. The specimens without
visible blood vessel were labelled 0, the specimens with a
small number of vessels – as 1, those with the average
number of vessels – as 2 and, finally, the specimens with
a big number of vessels as 3.
The study was approved by the Bioethics Committee
of the Medical University. Written informed consent for
participation in the study was obtained from children’
parents or guardians.
Immunohistochemistry
An immunohistochemical study was performed, using
the rabbit anti-substance P polyclonal antibody (Chemi-
con International, Inc.) and the S-100 protein mouse
monoclonal antibody (Novocastra, UK). Paraffin sections
were mounted onto superfrozen slides and deparaffi-
nised. After re-hydration, the sections were for 5 minutes
reacted with 3% hydrogen peroxide in distilled water
and rinsed in Tris buffered saline (TBS). Afterwards, the
slides were overnight incubated in a moist chamber with
the rabbit anti-substance P antibody in 1:2000 dilu-
tion and at 4°C. Then, the sections were rinsed in
TBS and a DAKO LSAB+/HRP Universal Kit (DAKO
A/S, Glostrup, Denmark) was used, according to the
manufacturer’s instructions. Positive immunoreactiv-
ity was visualized with DAB as chromogen. The sec-
tions were washed in distilled water, counter-stained
with H&E and coverslipped with DPX mounting medium.
Negative controls were carried out by incubation in the
absence of the primary body – the results being always
negative. A similar procedure was performed with the
S-100 protein mouse monoclonal antibody (Novocastra,
UK) – (the slides were incubated with S-100 in 1:25 dilu-
tion for 60 minutes).
Assessment method of SP immunopositive fibres
The slices were semi-quantitatively examined for sub-
stance P expression, showing nerve fibres, counted in 10
visual fields (lens magnification: ×40). The numbers of
immunoreactive fibres were graded as follows:
0 - lack of nerve fibres with substance P expression
1 - one or more immunopositive nerve fibres with
substance P expressionIn each case, the arithmetic mean of SP immunoposi-
tive fibres was assessed for the ten visual fields. A similar
procedure was performed with S-100 protein.
The density of nociceptive fibres, exposed by anti-
bodies against Substance P (SP) and S-100 protein and
the vascularity of specimens were evaluated in children
with DDH and CP with painful and painless hip joints.
Statistical analysis – the U Mann-Whitney test was
used.Results
The obtained results indicate that the statistically signifi-
cantly more frequent positive immunohistochemical re-
action to S-100 protein concerned structures of the
femoral head ligaments in children with CP and cartilage
losses on the femoral head, when compared to the same
structures in children with DDH (p = 0.010). Also more
frequent were found positive immunohistochemical re-
actions for S-100 protein in the joint capsules of chil-
dren with cartilage losses (p = 0.031) and pain ailments
vs. the children with DDH (p = 0.027). Similarly, the sta-
tistically significantly more frequent positive reaction to
substance P concerned structures of the femoral head
ligaments in children with CP and cartilage lesions (p =
0.002) or with pain ailments (p = 0.001) vs. the children
with DDH. An analysis of the vascularisation degree of
the femoral head ligament and of the joint capsule did
not show any statistically significant differences between
patients of either DDH or CP group, see Table 2 for de-
tailed data.
Almost all the children with CP and cartilage defects
demonstrated positive immunohistochemical reactions
to S-100 protein, substance P or to both studied markers
in the articular capsule and/or in the round ligament
(Table 3).
In our study, pain was found in 57.9% of the CP chil-
dren but not in the DDH patients. 11 CP patients with
pain demonstrated higher SP and S-100 densities, when
compared to CP patients without pain. In the pain-
suffering CP children, both proteins, i.e., S-100 and SP,
were present in the teres ligament and in the capsule,
72.7% and 36.4%, respectively. Moreover, only in 3 cases
was SP immunoreactivity in the joint capsule found un-
accompanied by S-100 (Figure 1).Discussion and conclusions
Clinical and radiological symptoms of dislocated hip
joint in DDH and CP are almost identical. Even surgical
treatment methods of both groups are almost the same.
However, the clinical practice shows that pain sensations
of dislocated hip joint are more frequently observed in
children with CP, which are born with normally developed
hip joint, while the loss of contact between articular
Table 2 Correlation-DDH and CP group
CP (n = 19)
Painless (n = 8) Painfull (n = 11) Without cartilage
damage (n = 10)
With cartilage
damage (n = 9)
Teres
ligament
Blood vessels number Z = 0,78, p = 0,437 Z = 1,29, p = 0,198 Z = 0,09, p = 0,930 Z = 0,83, p = 0,408
DDH (n = 15)
S-100 (number of
positive structures)
Z = 1,06, p = 0,289 Z = 1,95, p = 0,052 Z = 1,31, p = 0,190 Z = 2,59*, p = 0,010*
Substance P (number of
positive structures)
Z = 0,70, p = 0,482 Z = 3,29*, p = 0,001* Z = 0,000, p > 0,999 Z = 3,12*, p = 0,002*
Joint
capsule
Blood vessels number Z = 1,48, p = 0,140 Z = 1,57, p = 0,116 Z = 1,54, p = 0,124 Z = 1,51, p = 0,131
S-100 (number of positive
structures)
Z = 1,06, p = 0,290 Z = 2,21*, p = 0,027* Z = 0,25, p = 0,806 Z = 2,16*, p = 0,031*
Substance P (number of
positive structures)
Z = 1,64, p = 0,101 Z = 1,42, p = 0,157 Z = 1,17, p = 0,243 Z = 1,89, p = 0,060
*results statistically significant.
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age after 3-5 years [10,16,17].
Numerous studies, concerning the distribution of noci-
ceptive endings in the anatomical structures of various
joints and the attempts to analyse their role in pain induc-
tion, have already been described in the literature [18-21].
However, there has, so far, been no comparison of noci-
ceptor distribution in hip joint structures of patients with
hip joint dislocation in the course of cerebral palsy and de-
velopmental dysplasia of the hip or a proper analysis,
explaining the effect of differences in this distribution on
the occurrence of joint pain sensations.
In our studied groups, pain occurred in more than a
half of the patients with cerebral palsy, while such sensa-
tions were not observed in the patients with DDH. In all
the children with cerebral palsy and cartilage defects,
positive immunohistochemical reactions were found for
S-100 protein, substance P or for both studied markers
in the joint capsule and/or the femoral head ligament.
In comparison with patients with hip joint dislocation
in the course of developmental dysplasia, a positive
immunohistochemical reaction to S-100 protein moreTable 3 S-100 protein and Substance P distribution in CP
patients and cartilage damage
Patient no. (with
cartilage damage)
Teres ligament Joint capsule
S100 Substance P S100 Substance P
1. + + - -
4. - + + -
5. + + + +
9. + + - -
11. + + + +
12. + + - -
15. + + - -
16. + + + -
17. - - - +frequently concerned structures of the femoral head
ligament in children with CP and cartilage defects on
the femoral head. Positive immunohistochemical reac-
tions to S-100 protein were also more frequent in the
joint capsules of children with CP and cartilage defects
and pain sensations than in children with DDH. It was
also found that a positive immunohistochemical reac-
tion for substance P concerned more often the struc-
tures of the femoral head ligament in children with CP
and cartilage defects or pain sensations, when com-
pared to children with DDH.
Saxler et al. observed a 2.5× higher level of immuno-
positive nerve fibres for substance P and CGRP in struc-
tures of osteoarthritis hip joint vs. a control group [20].
Similarly in our studies, a significantly higher content of
immunopositive fibres for S-100 protein was found in
the femoral head ligament and in the articular capsule of
patients with CP, when compared with preparations
from the patients with DDH.
The relationship, observed between the occurrence of
substance P and S-100 protein and pain intensity in the
groups of children with cerebral palsy and with DDH , un-
equivocally confirmed that pain in the previous group was
associated with an increased expression of both these fac-
tors. It was particularly distinctive in the femoral head liga-
ment, while less in the joint capsule. In patients, suffering
from pain, both markers were higher vs. the group with
DDH, in which no pain was observed. Also femoral head
cartilage defects in the group of patients with CP were as-
sociated with a higher expression of both markers, both in
the joint capsule and in the femoral head ligament. These
differences emphasise the specific role of inflammatory
process, present in defective tissues. This hypothesis was
confirmed by authors, suggesting that proteins of the S-100
family, released into the extracellular environment, could
play the role of a pro-catabolic and pro-inflammatory fac-
tors which stimulate cell proliferation and joint cartilage
degradation [22,23].
Figure 1 S-100 protein and substance P percentage distribution in the teres ligament and the capsule in groups of CP and DDH patients.
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important aspect, concerning possible predispositions to
hip joint pain in children with CP, depending on the
density of nociceptor layout. In 8, out of eleven (72.7%)
cases of children with CP, suffering from hip joint pain,
there was a simultaneous increase in the number of
immunopositive fibres for substance P and S-100 protein
in the femoral head ligament. Pain intensity seems then
to be related to concomitant localisation of substance P
and S-100 protein, especially in the femoral head liga-
ment. In the group of children with DDH, the lack of
pain sensations correlate well with only limited, colocali-
sation of substance P- and S-100 protein-immunopositive
fibres (13.3%).
The aetiology of pain sensations in the group with CP
does not provide any clear indication why pain, associ-
ated with hip joint dislocation, occurs in some patients
only. In histopathological studies, free nerve endings
with nociceptive function were identified in all the joint
structures except the articular cartilage. Despite the lack
of innervation and vascularisation, cartilage defects in-
duce pain sensations of, so far, non defined aetiology. It
is very well possible that an accumulation of microtrau-
mas may lead to cartilage wear, as well as to osteoporotic
fractures [24]. Also a gradual loss of the articular cartil-
age may lead to pain sensation and reduced articular
mobility, resulting from an exposure of nerve endings in
the subchondral layer.
It cannot be excluded that an increased density of the
nerve fibres indicating expression for substance P, may
be a consequence of direct and indirect inflammatory
processes that take place in degenerative and defective
joint structures around the cartilage [25,26].
Some authors have found immunopositive fibres for
substance P in articular structures, such as the synovialmembrane, the meniscus and ligands [26]. The presence
of substance P-containing nerve fibres in the femoral
head ligament, may suggest their important, nociceptive
role in the hip joint, supportive for the development of
pathophysiological processes in the femoral head liga-
ment and the joint capsule. Their intensity and scope
demonstrate among others Witoński and Wagrowska-
Danilewicz [27]. They found that the number of P-positive
nerve fibres was not constant and might undergo a certain
increase during a 4-month period from the injury. Also in
our groups of patients, the time period of irritating the
femoral head ligament and joint capsule tissues was differ-
ent, what resulted from the already mentioned changes in
the hip joint in the course of developmental dysplasia,
which have their beginning already in the foetal life.
The question still remains unanswered, whether there
is any relationship between the occurrence of hip joint
pain in children with CP and the density of nociceptors.
The results of studies by Maslon et al. [13], as well as of
studies by other authors [20], confirm that there is such
a relationship, moreover indicating a specific relation-
ship between the density of substance P-positive fibres
and pain occurrence. In hip joint dislocation in the
course of spasticity as well as in the presence of other
aetiological factors, leading to pain induction by the hip
joint, an increased density of nociceptive fibres is closely
related with pain intensity. The whole set of complex ac-
tivities, including the activation of nerve fibres, immuno-
positive for substance P and S-100 protein, initiates
important cellular processes which, in turn, trigger a
number of secondary, intracellular transmitter systems,
especially protein kinases [26].
So huge clinical differences between CP and DDH
groups with dislocated hip joint, expressed in the fre-
quency of pain, seems to taking its source in tissue
Grzegorzewski et al. BMC Musculoskeletal Disorders 2014, 15:96 Page 6 of 6
http://www.biomedcentral.com/1471-2474/15/96sensitization and inflammatory process or articular car-
tilage defects. At present, the only way to stop the ad-
verse biological processes is early surgical treatment.
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